| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, General & Internal |
| Manuscript Type |
Case Report |
| Article Title |
Clinical evolution of antisynthetase syndrome associated interstitial lung disease after COVID-19 in a man with Klinefelter syndrome: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiang-Xiang Wu, Jian Cui, Shi-Yao Wang, Tian-Tian Zhao, Ya-Fei Yuan, Long Yang, Wei Zuo and Wen-Jian Liao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Jiangxi province |
20202BAB206002, 20224BAB216084 |
|
| Corresponding Author |
Wen-Jian Liao, PhD, Doctor, Doctor, Department of Respiratory and Critical Care, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 17 Yongwaizheng Street, Nanchang 330006, Jiangxi Province, China. 897854867@qq.com |
| Key Words |
Antisynthetase syndrome; COVID-19; Klinefelter syndrome; Interstitial lung disease; Anti-Jo-1; Case report |
| Core Tip |
Antisynthetase syndrome (AS) presents as an idiopathic inflammatory muscle disease typified by the presence of anti-Jo1 antibodies. Mainstream treatments encompass corticosteroids and immunosuppressants. Occasionally, certain rheumatic immune diseases can be precipitated by infectious diseases. Herein, we present a case detailing the rapid onset of respiratory failure due to AS subsequent to coronavirus disease 2019 (COVID-19) in an individual diagnosed with Klinefelter syndrome (KS). Following a multidisciplinary discussion, the conclusive diagnosis for the patient’s rapid respiratory decline was AS. This investigation accentuates the clinical progression of AS associated interstitial lung disease following viral infections such as COVID-19 in individuals with KS. |
| Publish Date |
2024-02-20 09:51 |
| Citation |
Wu XX, Cui J, Wang SY, Zhao TT, Yuan YF, Yang L, Zuo W, Liao WJ. Clinical evolution of antisynthetase syndrome associated interstitial lung disease after COVID-19 in a man with Klinefelter syndrome: A case report. World J Clin Cases 2024; 12(6): 1144-1149 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i6/1144.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i6.1144 |
